Recruiting
Phase 2

ZEN003694 & Enzalutamide

Sponsor:

Zenith Epigenetics

Code:

NCT04986423

Conditions

Metastatic Castration-Resistant Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ZEN003694

Enzalutamide

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-02. This information was provided to ClinicalTrials.gov by Zenith Epigenetics on 2025-01-24.